If you need more lookups,
subscriptions start at $34 USD/month.
Stacy Lindborg Location
United States
Stacy Lindborg Work
President and Chief Executive Officer, Board Director @ (May 2024 - Present)
Board Director @ (June 2021 - May 2024)
Board Member @ (May 2024 - Present)
Co-Chief Executive Officer @ (January 2023 - May 2024)
Executive Vice President and Chief Development Officer @ (November 2021 - January 2023)
Executive Vice President and Head of Global Clinical Research @ (May 2020 - November 2021)
Chair of the Board of Directors @ (March 2019 - Present)
Vice President, Analytics and Data Science @ (September 2018 - January 2020)
Vice President, Biometrics @ (August 2014 - September 2018)
Sr. Director, Biostatistics @ (January 2012 - August 2014)
Sr. Director, Global Statistics and Advanced Analytics @ Eli Lilly and Company (January 2010 - January 2012)
Global Head, Research and Development Strategy @ Eli Lilly and Company (March 2008 - December 2009)
Head, Decision Sciences @ Eli Lilly and Company (March 2008 - December 2009)
Quantitative Pharmacology, Board Member @ Eli Lilly and Company (January 2005 - February 2008)
Global Head, Exploratory and Program Medical Statistics @ Eli Lilly and Company (November 2004 - February 2008)
Global Statistics Leader, Biomarker Research @ Eli Lilly and Company (January 2002 - January 2008)
Zyprexa Product team leader covering Schizophrenia, Acute Patient, Franchise Team @ Eli Lilly and Company (January 2001 - September 2002)
Senior Statistician, Zyprexa Product Team @ Eli Lilly and Company (August 1996 - January 2001)
Stacy Lindborg Education
Baylor University
Ph.D. (Statistics)
1992-1996
Stacy Lindborg Skills
Drug Development
Pharmaceutical Industry
Clinical Development
Biostatistics
Clinical Trials
Biotechnology
GCP
Oncology
Clinical Research
Regulatory Submissions
SAS
FDA
Clinical Data Management
CRO
Bioinformatics
CDISC
Strategy
EDC
Clinical Study Design
Biomarkers
Statistical Modeling
Neuroscience
Lifesciences
Medical Affairs
Survival Analysis
Therapeutic Areas
Statistical Programming
Pharmacokinetics
CRO Management
Infectious Diseases
Life Sciences
Medical Writing
U.S. Food and Drug Administration (FDA)
Data Analysis
Project Management
Stacy Lindborg Summary
Stacy Lindborg, based in United States, is currently a President and Chief Executive Officer, Board Director at IMUNON. Stacy Lindborg brings experience from previous roles at IMUNON and Brainstorm Cell Therapeutics. Stacy Lindborg holds a 1992 - 1996 Ph.D. in Statistics @ Baylor University. With a robust skill set that includes Drug Development, Pharmaceutical Industry, Clinical Development, Biostatistics, Clinical Trials and more. Stacy Lindborg has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Stacy Lindborg?
Find contact details for 700 million professionals.